Epilepsy continues to remain an important cause of disability and mortality. Despite newer innovations in epilepsy therapy, there remains significant unmet medical needs and treatment challenges. We Cordially invite to watch this CME which aims in expanding knowledge regarding the pathophysiological mechanisms, molecular-target-driven approaches, and the emerging role of pharmacogenomics in the discovery of newer epilepsy treatments.
Click the linkt to know more: https://www.omnicuris.com/oclive/11529
AboutMyClinic